Novel ACTG1 mutations in patients identified by massively parallel DNA sequencing cause progressive hearing loss

Sci Rep. 2020 Apr 27;10(1):7056. doi: 10.1038/s41598-020-63690-5.


Human ACTG1 mutations are associated with high-frequency hearing loss, and patients with mutations in this gene are good candidates for electric acoustic stimulation. To better understand the genetic etiology of hearing loss cases, massively parallel DNA sequencing was performed on 7,048 unrelated Japanese hearing loss probands. Among 1,336 autosomal dominant hearing loss patients, we identified 15 probands (1.1%) with 13 potentially pathogenic ACTG1 variants. Six variants were novel and seven were previously reported. We collected and analyzed the detailed clinical features of these patients. The average progression rate of hearing deterioration in pure-tone average for four frequencies was 1.7 dB/year from 0 to 50 years age, and all individuals over 60 years of age had severe hearing loss. To better understand the underlying disease-causing mechanism, intracellular localization of wild-type and mutant gamma-actins were examined using the NIH/3T3 fibroblast cell line. ACTG1 mutants p.I34M p.M82I, p.K118M and p.I165V formed small aggregates while p.R37H, p.G48R, p.E241K and p.H275Y mutant gamma-actins were distributed in a similar manner to the WT. From these results, we believe that some part of the pathogenesis of ACTG1 mutations may be driven by the inability of defective gamma-actin to be polymerized into F-actin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / genetics*
  • Actins / metabolism
  • Adolescent
  • Adult
  • Animals
  • Child
  • Child, Preschool
  • Female
  • Hearing Loss / genetics*
  • Humans
  • Immunohistochemistry
  • Male
  • Mice
  • Middle Aged
  • Mutation / genetics*
  • Mutation, Missense / genetics
  • NIH 3T3 Cells
  • Sequence Analysis, DNA
  • Young Adult


  • ACTG1 protein, human
  • Actins